Core Viewpoint - Sanofi Pharmaceutical (01530) announced a share placement agreement to raise approximately HKD 31.15 billion, with a share price discount compared to recent trading prices [1] Group 1: Share Placement Details - The company will issue 105 million shares at a price of HKD 29.62 per share [1] - The placement price represents a 6.50% discount to the closing price of HKD 31.68 on the trading day prior to the agreement [1] - The average closing price over the previous five trading days was HKD 31.28, indicating a discount of approximately 5.29% [1] Group 2: Fund Utilization - Approximately 80% of the raised funds will be allocated to research and development expenditures, focusing on advancing clinical studies for innovative drugs [1] - The remaining 20% will be used for operational funding and other general purposes [1]
三生制药拟配售1.05亿股 净筹30.87亿港元 八成用于研发